Gastric cancer (GC) is one of the most common tumors worldwide and the leading cause of
tumor-related mortality. Endoscopy and serological tumor marker testing are currently the …

Gastric cancer (GC) is a high-incidence cancer worldwide. Most patients are diagnosed at
an advanced stage, by which time they have limited treatment options and poor prognosis …

Cancer has a high mortality rate across the globe, and tissue biopsy remains the gold
standard for tumor diagnosis due to its high level of laboratory standardization, good …

The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …

DNA methylation profiles are in dynamic equilibrium via the initiation of methylation,
maintenance of methylation and demethylation, which control gene expression and …

Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to
inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy …

From a global perspective, gastric cancer (GC) persists as a significant healthcare issue. In
the Western world, the majority of cases are discovered at late stages, when the treatment is …

Gastric cancer (GC) is a very common malignancy with a poor prognosis, and its occurrence
and development are closely related to epigenetic modifications. Methylation of DNA before …

Over the next few years, the analysis of circulating tumor DNA (ctDNA) through liquid biopsy
is expected to enter clinical practice and revolutionize the approach to biomarker testing and …

DNA methylation is known to be involved in tumor progression. This is the first study to
perform an extensive methylation analysis of plasma circulating tumor DNA (ctDNA) using …